{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:54:49Z","timestamp":1771854889189,"version":"3.50.1"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Burn injury results in hypercoagulability and an increased venous thromboembolism risk. However, the most effective chemoprophylaxis for burn-injured patients has yet to be elucidated. Therefore, this study aims to identify the safety and efficacy of a burn center\u2019s venous thromboembolism protocol modification, which increased the dose of enoxaparin from 40 mg daily to 40mg twice daily with peak anti-Xa level adjustments. It was hypothesized that this change would not increase bleeding complications and would decrease venous thromboembolism rates. All adult, burn-injured patients admitted to a regional burn center were retrospectively reviewed 1 year before and after the implementation of this protocol modification. There were no differences in demographics, injury characteristics, or hospital length of stay between the pre- (n = 432) and postprotocol modification (n = 407) groups. Bleeding complications did not increase in the postprotocol group, including intraoperative blood loss (50 vs 25cc), the total number of transfusions (9.0 vs 6.0 units), and GI bleeding events (0.7 vs 0.2%) (all P &amp;gt; .05). Most patients receiving enoxaparin 40 mg twice daily achieved an initial therapeutic level based on peak anti-Xa measurements (46.5%), yet the rate of venous thromboembolisms between pre- and postprotocol groups was not statistically different (1.4 vs 0.7%, P = .5072). Factors associated with an initial sub- or supratherapeutic peak anti-Xa level were percent total body surface area, weight, body mass index, and creatinine clearance. Overall, this study demonstrated that a higher dose of enoxaparin (40 mg twice daily) with peak anti-Xa level adjustments was safe in burn-injured patients and necessary to obtain therapeutic levels of chemoprophylaxis.<\/jats:p>","DOI":"10.1093\/jbcr\/irae201","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T23:16:39Z","timestamp":1731798999000},"page":"495-503","source":"Crossref","is-referenced-by-count":2,"title":["Enoxaparin 40 mg Twice Daily With Peak Anti-Xa Adjustments Is Safe and Necessary to Achieve Therapeutic Chemoprophylaxis in Burn-Injured Patients"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5509-7773","authenticated-orcid":false,"given":"Desiree N","family":"Pinto","sequence":"first","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]},{"name":"Department of Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4193-4987","authenticated-orcid":false,"given":"Sophia","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, MedStar Washington Hospital Center , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7474-1517","authenticated-orcid":false,"given":"Cory","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, MedStar Washington Hospital Center , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6828-1793","authenticated-orcid":false,"given":"Rola","family":"Halabi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, MedStar Washington Hospital Center , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1539-6346","authenticated-orcid":false,"given":"Tuan D","family":"Le","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren T","family":"Moffatt","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]},{"name":"Department of Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]},{"name":"The Burn Center, Department of Surgery, MedStar Washington Hospital Center , Washington, DC,","place":["United States"]},{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2292-4960","authenticated-orcid":false,"given":"Bonnie C","family":"Carney","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]},{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-9467","authenticated-orcid":false,"given":"Shane K","family":"Mathew","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-2509","authenticated-orcid":false,"given":"Melissa","family":"McLawhorn","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Tejiram","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]},{"name":"Department of Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]},{"name":"The Burn Center, Department of Surgery, MedStar Washington Hospital Center , Washington, DC,","place":["United States"]},{"name":"Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0519-4388","authenticated-orcid":false,"given":"Taryn E","family":"Travis","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]},{"name":"Department of Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]},{"name":"The Burn Center, Department of Surgery, MedStar Washington Hospital Center , Washington, DC,","place":["United States"]},{"name":"Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W","family":"Shupp","sequence":"additional","affiliation":[{"name":"Firefighters\u2019 Burn and Surgical Research Laboratory, MedStar Health Research Institute , Washington, DC,","place":["United States"]},{"name":"Department of Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]},{"name":"The Burn Center, Department of Surgery, MedStar Washington Hospital Center , Washington, DC,","place":["United States"]},{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine , Washington, DC,","place":["United States"]},{"name":"Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine , Washington, DC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"2025081301371060500_CIT0001","doi-asserted-by":"publisher","first-page":"zrab017","DOI":"10.1093\/bjsopen\/zrab017","article-title":"Early abnormal fibrinolysis and mortality in patients with thermal injury: a prospective cohort study","volume":"5","author":"Pusateri","year":"2021","journal-title":"BJS Open"},{"key":"2025081301371060500_CIT0002","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.burns.2011.06.006","article-title":"A survey of current practice patterns in prophylaxis against venous thromboembolism (VTE) and gastrointestinal (GI) ulceration among Canadian burn centers","volume":"37","author":"Abedi","year":"2011","journal-title":"Burns"},{"key":"2025081301371060500_CIT0003","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-0034-1398380","article-title":"Hypercoagulability and venous thromboembolism in burn patients","volume":"41","author":"Meizoso","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"2025081301371060500_CIT0004","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/SHK.0000000000001484","article-title":"Burn-induced coagulopathies: a comprehensive review","volume":"54","author":"Ball","year":"2020","journal-title":"Shock"},{"key":"2025081301371060500_CIT0005","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004630-200103000-00008","article-title":"Potential risk factors for deep venous thrombosis in burn patients","volume":"22","author":"Wahl","year":"2001","journal-title":"J Burn Care Rehabil"},{"key":"2025081301371060500_CIT0006","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2522\/ptj.20110417","article-title":"Effectiveness of an early mobilization protocol in a trauma and burns intensive care unit: a retrospective cohort study","volume":"93","author":"Clark","year":"2013","journal-title":"Phys Ther"},{"key":"2025081301371060500_CIT0007","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1182\/asheducation-2014.1.306","article-title":"Central venous catheter-related thrombosis","volume":"2014","author":"Geerts","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2025081301371060500_CIT0008","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.burns.2022.09.011","article-title":"VTE prophylaxis and anti-factor Xa measurement in major burns: a survey of UK practice","volume":"49","author":"Payne","year":"2023","journal-title":"Burns"},{"key":"2025081301371060500_CIT0009","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.burns.2019.04.003","article-title":"Thromboprophylaxis in adult and paediatric burn patients: a survey of practice in the United Kingdom","volume":"45","author":"Vermaak","year":"2019","journal-title":"Burns"},{"key":"2025081301371060500_CIT0010","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.burns.2018.08.006","article-title":"Stratification of venous thromboembolism risk in burn patients by Caprini score","volume":"45","author":"Li","year":"2019","journal-title":"Burns"},{"key":"2025081301371060500_CIT0011","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.burns.2006.02.018","article-title":"Complications of the hypercoagulable status in burn injury","volume":"32","author":"Barret","year":"2006","journal-title":"Burns"},{"key":"2025081301371060500_CIT0012","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/BF02067085","article-title":"Thromboembolic complications in thermally injured patients","volume":"16","author":"Rue","year":"1992","journal-title":"World J Surg"},{"key":"2025081301371060500_CIT0013","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/jbcr\/iraa143","article-title":"Venous thromboembolism chemoprophylaxis in burn patients: a literature review and single-institution experience","volume":"42","author":"Liu","year":"2021","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0014","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/TA.0000000000002538","article-title":"Venous thromboembolism chemoprophylaxis regimens in trauma and surgery patients with obesity: a systematic review","volume":"88","author":"Shaikh","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"2025081301371060500_CIT0015","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"2025081301371060500_CIT0016","article-title":"Deep venous thrombosis prophylaxis. 2023 May 7","volume-title":"StatPearls","author":"Badireddy","year":"2025"},{"key":"2025081301371060500_CIT0017","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamasurg.2017.3787","article-title":"Association of anti-factor Xa-guided dosing of enoxaparin with venous thromboembolism after trauma","volume":"153","author":"Karcutskie","year":"2018","journal-title":"JAMA Surg"},{"key":"2025081301371060500_CIT0018","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/1060028016683970","article-title":"Increased enoxaparin dosing for venous thromboembolism prophylaxis in general trauma patients","volume":"51","author":"Walker","year":"2017","journal-title":"Ann Pharmacother"},{"key":"2025081301371060500_CIT0019","article-title":"Enoxaparin. 2023 Aug 28","volume-title":"StatPearls","author":"Jupalli","year":"2025"},{"key":"2025081301371060500_CIT0020","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/TA.0b013e3181d32271","article-title":"Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients","volume":"68","author":"Malinoski","year":"2010","journal-title":"J Trauma"},{"key":"2025081301371060500_CIT0021","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jss.2015.10.028","article-title":"Non-weight-based enoxaparin dosing subtherapeutic in trauma patients","volume":"201","author":"Chapman","year":"2016","journal-title":"J Surg Res"},{"key":"2025081301371060500_CIT0022","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/cc12684","article-title":"A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial","volume":"17","author":"Robinson","year":"2013","journal-title":"Crit Care"},{"key":"2025081301371060500_CIT0023","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2165\/00003088-200847100-00002","article-title":"Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients","volume":"47","author":"Blanchet","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"2025081301371060500_CIT0024","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1097\/BCR.0000000000000120","article-title":"Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review","volume":"36","author":"Steele","year":"2015","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0025","doi-asserted-by":"publisher","first-page":"C58","DOI":"10.1152\/ajpcell.00106.2021","article-title":"Burn-induced hypermetabolism and skeletal muscle dysfunction","volume":"321","author":"Knuth","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"2025081301371060500_CIT0026","doi-asserted-by":"publisher","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"2025081301371060500_CIT0027","volume-title":"Lovenox (Enoxaparin) Package Insert","author":"Sanofi Aventis","year":"2009"},{"key":"2025081301371060500_CIT0028","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/BCR.0b013e318204b2ff","article-title":"Venous thromboembolism in thermally injured patients: analysis of the National Burn Repository","volume":"32","author":"Pannucci","year":"2011","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0029","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/00005373-199302000-00015","article-title":"A prospective study of blood loss with excisional therapy in pediatric burn patients","volume":"34","author":"Housinger","year":"1993","journal-title":"J Trauma"},{"key":"2025081301371060500_CIT0030","doi-asserted-by":"publisher","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"2025081301371060500_CIT0031","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cps.2017.02.002","article-title":"Venous thromboembolism in patients with thermal injury: a review of risk assessment tools and current knowledge on the effectiveness and risks of mechanical and chemical prophylaxis","volume":"44","author":"Pannucci","year":"2017","journal-title":"Clin Plast Surg"},{"key":"2025081301371060500_CIT0032","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/TA.0000000000003475","article-title":"American Association for the Surgery of Trauma\/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma","volume":"92","author":"Yorkgitis","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"key":"2025081301371060500_CIT0033","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.burns.2005.06.011","article-title":"Current practice of thromboprophylaxis in the burn population: a survey study of 84 US burn centers","volume":"31","author":"Ferguson","year":"2005","journal-title":"Burns"},{"key":"2025081301371060500_CIT0034","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/BCR.0B013E318148C887","article-title":"Practice guidelines for deep venous thrombosis prophylaxis in burns","volume":"28","author":"Faucher","year":"2007","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0035","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00068-024-02443-9","article-title":"Comparison of the safety and efficacy for different regimens of pharmaco-prophylaxis among severely burned patients: a randomized controlled trial","volume":"50","author":"Al Sulaiman","year":"2024","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2025081301371060500_CIT0036","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/jbcr\/irad074","article-title":"The association between the timing of initiation of pharmacologic venous thromboembolism prophylaxis with outcomes in burns patients","volume":"44","author":"Castanon","year":"2023","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0037","doi-asserted-by":"publisher","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"2025081301371060500_CIT0038","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1177\/000313481508100725","article-title":"Association between Interruptions in Chemical Prophylaxis and VTE Formation","volume":"81","author":"Ramanathan","year":"2015","journal-title":"Am Surg"},{"key":"2025081301371060500_CIT0039","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jamasurg.2013.3963","article-title":"Correlation of missed doses of enoxaparin with increased incidence of deep vein thrombosis in trauma and general surgery patients","volume":"149","author":"Louis","year":"2014","journal-title":"JAMA Surg"},{"key":"2025081301371060500_CIT0040","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jamcollsurg.2015.11.011","article-title":"Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism","volume":"222","author":"Selby","year":"2016","journal-title":"J Am Coll Surg"},{"key":"2025081301371060500_CIT0041","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/BCR.0b013e31827819a1","article-title":"Thromboembolic complications in burn patients and associated risk factors","volume":"34","author":"Mullins","year":"2013","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0042","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/BCR.0b013e3182a2a9f8","article-title":"Enoxaparin and antifactor Xa levels in pediatric acute burn patients","volume":"34","author":"Brown","year":"2013","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0043","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BCR.0b013e318204b346","article-title":"Enoxaparin and antifactor Xa levels in acute burn patients","volume":"32","author":"Lin","year":"2011","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0044","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/TA.0b013e31823070f9","article-title":"Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients","volume":"71","author":"Lin","year":"2011","journal-title":"J Trauma"},{"key":"2025081301371060500_CIT0045","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.burns.2019.02.011","article-title":"Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients","volume":"45","author":"Cronin","year":"2019","journal-title":"Burns"},{"key":"2025081301371060500_CIT0046","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.burns.2003.12.019","article-title":"Analysis of deep vein thrombosis in burn patients","volume":"30","author":"Fecher","year":"2004","journal-title":"Burns"},{"key":"2025081301371060500_CIT0047","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TA.0b013e3181271b8a","article-title":"Global evacuation of burn patients does not increase the incidence of venous thromboembolic complications","volume":"65","author":"Chung","year":"2008","journal-title":"J Trauma"},{"key":"2025081301371060500_CIT0048","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/ALN.0000000000000559","article-title":"Acute and perioperative care of the burn-injured patient","volume":"122","author":"Bittner","year":"2015","journal-title":"Anesthesiology"},{"key":"2025081301371060500_CIT0049","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2017.09.019","article-title":"The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics","volume":"123","author":"Udy","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"2025081301371060500_CIT0050","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/sur.2020.375","article-title":"Pharmacokinetics and pharmacodynamics of antimicrobial agents in burn patients","volume":"22","author":"Pruskowski","year":"2021","journal-title":"Surg Infect (Larchmt)"},{"key":"2025081301371060500_CIT0051","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/phar.2665","article-title":"Evaluation of anti-factor Xa concentrations using a body mass index-based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients","volume":"42","author":"O\u2019Keefe","year":"2022","journal-title":"Pharmacotherapy"},{"key":"2025081301371060500_CIT0052","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jss.2023.01.018","article-title":"Effectiveness of body mass index-based prophylactic enoxaparin dosing in bariatric surgery patients","volume":"287","author":"Chang","year":"2023","journal-title":"J Surg Res"},{"key":"2025081301371060500_CIT0053","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1345\/aph.1Q313","article-title":"Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients","volume":"45","author":"Ludwig","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2025081301371060500_CIT0054","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jbcr\/irab039","article-title":"Single-center experience with venous thromboembolism prophylaxis for obese burn patients","volume":"42","author":"McKinzie","year":"2021","journal-title":"J Burn Care Res"},{"key":"2025081301371060500_CIT0055","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1055\/s-0038-1651032","article-title":"The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement","volume":"62","author":"Levine","year":"1989","journal-title":"Thromb Haemost"},{"key":"2025081301371060500_CIT0056","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.amjsurg.2013.10.005","article-title":"Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer","volume":"206","author":"Kopelman","year":"2013","journal-title":"Am J Surg"}],"container-title":["Journal of Burn Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbcr\/advance-article-pdf\/doi\/10.1093\/jbcr\/irae201\/61035229\/irae201.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/46\/3\/495\/61035229\/irae201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/46\/3\/495\/61035229\/irae201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:37:18Z","timestamp":1755063438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbcr\/article\/46\/3\/495\/7921066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,12,11]]},"published-print":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jbcr\/irae201","relation":{},"ISSN":["1559-047X","1559-0488"],"issn-type":[{"value":"1559-047X","type":"print"},{"value":"1559-0488","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,11]]}}}